XML 180 R116.htm IDEA: XBRL DOCUMENT v3.8.0.1
Commitments and Contingencies (Details Textual) - USD ($)
$ in Millions
3 Months Ended 12 Months Ended
Dec. 31, 2017
Dec. 31, 2017
Dec. 31, 2016
Dec. 31, 2015
Dec. 31, 2006
Sep. 30, 2017
Jun. 30, 2017
Mar. 31, 2017
Jun. 30, 2013
Apr. 02, 2013
Business Acquisition [Line Items]                    
Maximum contingent consideration in the form of development and approval milestones $ 1,100.0 $ 1,100.0                
Increase to goodwill   1,267.3 $ 1,026.9              
Potential future milestone payments commitment, approximately 4,200.0 4,200.0                
Cancellable future commitments 460.0 460.0                
Commitments And Contingencies (Textual)                    
Accrued expenses 40.0 40.0                
Liabilities associated with uncertain tax positions 77.3 77.3                
Lease rent expense which terminates at various dates through 2028   65.3 68.7 $ 68.6            
TYSABRI                    
Business Acquisition [Line Items]                    
Future contingent payment for annual worldwide net sales up to $2.0 billion                   18.00%
Future contingent payment threshold                   $ 2,000.0
Future contingent payment for annual worldwide net sales that exceed $2.0 billion                   25.00%
Fumapharm AG                    
Business Acquisition [Line Items]                    
Amount paid in cash         $ 220.0          
Solothurn                    
Business Acquisition [Line Items]                    
Cancellable future commitments 270.0 270.0                
TECFIDERA | Fumapharm AG                    
Business Acquisition [Line Items]                    
Maximum contingent consideration in the form of development and approval milestones                 $ 15.0  
Increase to goodwill   1,500.0 1,200.0              
Fourteen billion | TECFIDERA | Fumapharm AG                    
Business Acquisition [Line Items]                    
Increase to goodwill   1,200.0                
Cumulative sales level           $ 14,000.0        
Eleven billion | TECFIDERA | Fumapharm AG                    
Business Acquisition [Line Items]                    
Cumulative sales level     $ 11,000.0              
Twelve billion | TECFIDERA | Fumapharm AG                    
Business Acquisition [Line Items]                    
Cumulative sales level               $ 12,000.0    
Thirteen billion | TECFIDERA | Fumapharm AG                    
Business Acquisition [Line Items]                    
Cumulative sales level             $ 13,000.0      
Fifteen billion | TECFIDERA | Fumapharm AG                    
Business Acquisition [Line Items]                    
Cumulative sales level 15,000.0 15,000.0                
Sixteen billion | TECFIDERA | Fumapharm AG                    
Business Acquisition [Line Items]                    
Increase to goodwill 600.0                  
Cumulative sales level 16,000.0 16,000.0                
One billion | TECFIDERA | Fumapharm AG                    
Business Acquisition [Line Items]                    
Cumulative sales level 1,000.0 1,000.0                
Each additional one billion up to twenty billion | TECFIDERA | Fumapharm AG                    
Business Acquisition [Line Items]                    
Increase to goodwill   300.0                
Cumulative sales level 20,000.0 20,000.0                
Three billion | TECFIDERA | Fumapharm AG                    
Business Acquisition [Line Items]                    
Cumulative sales level 3,000.0 3,000.0                
Development Milestones [Member]                    
Business Acquisition [Line Items]                    
Potential future milestone payments commitment, approximately 700.0 700.0                
Regulatory Milestones [Member]                    
Business Acquisition [Line Items]                    
Potential future milestone payments commitment, approximately 1,500.0 1,500.0                
Commercial Milestones [Member]                    
Business Acquisition [Line Items]                    
Potential future milestone payments commitment, approximately 2,000.0 2,000.0                
2017 Tax Act                    
Business Acquisition [Line Items]                    
Accrued income tax liability under the Transition Toll Tax 989.6 989.6                
Accrued income tax liability under the Transition Toll Tax, current $ 78.3 $ 78.3